Delivery Order SPE2DB22D1106-SPE2DB25FFDE0
- Not listed
- The Defense Logistics Agency awarded a $7,329.92 delivery order to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price contract represents a non-set-aside competitive award to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as...
- The Defense Logistics Agency awarded a delivery order valued at $1,218.96 to AmerisourceBergen Drug Corp for the supply of Promethegan 12.5 mg suppositories (12-count packages). This firm fixed-price delivery order, issued on July 26, 2025, with completion targeted for July 28, 2025, represents a routine pharmaceutical procurement supporting federal medical supply requirements. The award was made through open competition with no set-aside designation, and performance will be executed at the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a division of the Amerisourcebergen Corporation. The $2,827.80 firm-fixed-price contract is for the supply of the pharmaceutical drug Promethegan 25 mg suppositories. The contract has a completion date of May 6, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,794.40 firm fixed price delivery order to provide PROMETHEGAN 25 MG SUPPOSITORY 12S pharmaceutical products. This order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,154.16, is for the delivery of PROMETHEGAN 25 MG SUPPOSITORY 12S medical supplies. It is a firm fixed-price delivery order contract with a completion date of March 31, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Promethegan 25 mg suppositories, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $3,016.89 and a completion date of July 2, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is a...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $31,171.48 to AmerisourceBergen Drug Corp on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded contract supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $43,377.81 to AmerisourceBergen Drug Corp on August 18, 2025, with completion expected by August 19, 2025. This firm fixed-price, competitively awarded delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $1 billion and extends through December 2026. The delivery order represents a child contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $82,029.40 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $18,327.12 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFDE0Delivery Order
The Defense Logistics Agency awarded a $1,782.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Promethegan 25 mg suppositories (12-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of August 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, one of the nation's major pharmaceutical distributors, serves as a critical federal medical vendor primarily supporting the Defense Logistics Agency's medical supply chain and military healthcare systems. The company's extensive portfolio encompasses brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Through the SPE2DX prime indefinite delivery contract, AmerisourceBergen supplies pharmaceuticals and medical products to support military healthcare programs worldwide, including services to the Defense Health Agency and U.S. Coast Guard. The firm's consistent receipt of competitively awarded, non-set-aside delivery orders across a broad range of medical products demonstrates its established capability to meet federal procurement requirements for military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/14/25 |